Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
Open Access
- 1 March 1990
- journal article
- abstracts
- Published by Elsevier
- Vol. 265 (8), 4240-4246
- https://doi.org/10.1016/s0021-9258(19)39553-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Regulation of thromboxane receptor activation in human platelets.Proceedings of the National Academy of Sciences, 1989
- Monthly publication in 1986American Journal of Physiology-Cell Physiology, 1985
- A sulfhydryl group of the canine cardiac beta-adrenergic receptor observed in the absence of hormoneLife Sciences, 1985
- Receptors, acceptors, and the action of polypeptide hormones: illustrative studies with epidermal growth factor (urogastrone)Canadian Journal of Biochemistry and Cell Biology, 1983
- Phosphorylation activates the insulin receptor tyrosine protein kinase.Proceedings of the National Academy of Sciences, 1983
- Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor.Proceedings of the National Academy of Sciences, 1983
- Disulfide reduction converts the insulin receptor of human placenta to a low affinity form.Journal of Clinical Investigation, 1980
- Differences in organizational structure of insulin receptor on rat adipocyte and liver plasma membranes: role of disulfide bonds.Proceedings of the National Academy of Sciences, 1980
- Perturbation of the Insulin Receptor of Isolated Fat Cells with Proteolytic EnzymesPublished by Elsevier ,1971
- Dithiothreitol, a New Protective Reagent for SH Groups*Biochemistry, 1964